Product Portfolio with regulatory compliance

Alendronate Sodium

Bulk Active : Alendronate Sodium
Pharmacologic Activity : Anti-Osteoporosis
CAS No : 121268-17-5
Specifications : BP/EP/USP
Regulatory compliance : eDMF(CTD)

TEST USP 36 BP 2013/EP 7.4
     
CHARACTERS White, free-flowing powder. A white or almost white, crystalline powder,
     
SOLUBILITY Soluble in water, very slightly soluble in dimethyl sulfoxide, in methyl alcohol, and in propylene glycol; practically insoluble in acetone, in acetonitrile, in alcohol, in chloroform, and in isopropyl alcohol. soluble in water, very slightly soluble in methanol, practically insoluble in methylene chloride
     
IDENTIFICATION INFRARED ABSORPTION

Test for sodium
Infrared absorption spectrum of sample should be concordant with the reference spectrum of Alendronate Sodium Trihydrate It should respond to the test for Sodium. Infrared absorption spectrum of sample should be concordant with the reference spectrum of Sodium Alendronate working reference standard.

It should respond to the test for Sodium
     
Appearance of solution ----- Solution S is clear and not more intensely coloured than reference solution B7 or BY7.
     
pH of Solution S ----- Between 4.0 to 5.0
     
     
4-Aminobutanoic acid by TLC ----- Any spots corresponding to 4-aminobutanoic acid in the chromatogram obtained with the test solution are not more intense than the spot in the chromatogram obtained with reference solution (b) (0.5 per cent).
     
Phosphate
Phosphite
Individual Impurity
Total mpurity
------
------
NMT 0.1%
NMT 0.5%
NMT 0.5%
NMT 0.5%
------
------
     
LOSS ON DRYING Between 16.1% to 17.1% W/W Between 16.1% to 17.1% W/W
     
HEAVY METALS Not more than 0.001% NMT 10 ppm
     
ASSAY Between 98.0% and 102.0% w/w Between 98.0% and 102.0% w/w